XML 23 R11.htm IDEA: XBRL DOCUMENT
v3.20.2

Revenues from Contracts with Customers | 6 Months Ended
--- | ---
Jun. 30, 2020
Revenue from Contract with Customer [Abstract] |
Revenue from Contracts with Customers | 3. Revenue from Contracts with Customers. We recognize revenue when a customer obtains control of promised goods. The amount of revenue recognized reflects the consideration we expect to receive in exchange for these goods. Our revenue recognition policies have not changed from those disclosed in Note 2 to our consolidated financial statements in Item 8 of the Annual Report on Form 10-K. Disaggregation of Revenue The disaggregation of revenue is based on reporting segment, product category and geographical region. Beginning in the first quarter of 2020, we revised our product categories to more clearly reflect how we sell our products to our customers. We presented historical information under the new revised product categories in a Current Report on Form 8-K, filed with the SEC on April 3, 2020. We design, develop, manufacture and market medical products for interventional and diagnostic procedures. For financial reporting purposes, we report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of four product categories: peripheral intervention, cardiac intervention, custom procedural solutions, and OEM. Within these product categories, we sell a variety of products, including cardiology and radiology devices (which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases), as well as embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, breast cancer localization and guidance, biopsy, and interventional oncology and spine devices. Our endoscopy segment consists of gastroenterology and pulmonology devices which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. The following tables present revenue from contracts with customers by reporting segment, product category and geographical region for the three and six-month periods ended June 30, 2020 and 2019 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended | ​ | Three Months Ended
​ | ​ | June 30, 2020 | ​ | June 30, 2019
​ |  | United States |  | International |  | Total |  | United States |  | International |  | Total
Cardiovascular |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Peripheral Intervention | ​ | $ | 42,614 | ​ | $ | 30,021 | ​ | $ | 72,635 | ​ | $ | 55,975 | ​ | $ | 32,873 | ​ | $ | 88,848
Cardiac Intervention | ​ |  | 22,698 | ​ | ​ | 43,307 | ​ |  | 66,005 | ​ |  | 29,145 | ​ |  | 50,498 | ​ |  | 79,643
Custom Procedural Solutions | ​ |  | 23,383 | ​ | ​ | 21,936 | ​ |  | 45,319 | ​ |  | 25,150 | ​ |  | 22,066 | ​ |  | 47,216
OEM | ​ |  | 23,607 | ​ | ​ | 4,611 | ​ |  | 28,218 | ​ |  | 25,843 | ​ |  | 5,116 | ​ |  | 30,959
Total | ​ |  | 112,302 | ​ | ​ | 99,875 | ​ |  | 212,177 | ​ |  | 136,113 | ​ |  | 110,553 | ​ |  | 246,666
​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Endoscopy | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Endoscopy devices | ​ |  | 5,838 | ​ |  | 356 | ​ |  | 6,194 | ​ |  | 8,549 | ​ |  | 317 | ​ |  | 8,866
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 118,140 | ​ | $ | 100,231 | ​ | $ | 218,371 | ​ | $ | 144,662 | ​ | $ | 110,870 | ​ | $ | 255,532
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Six Months Ended | ​ | Six Months Ended
​ | ​ | June 30, 2020 | ​ | June 30, 2019
​ |  | United States |  | International |  | Total |  | United States |  | International |  | Total
Cardiovascular |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |  |  | ​ |
Peripheral Intervention | ​ | $ | 98,416 | ​ | $ | 61,294 | ​ | $ | 159,710 | ​ | $ | 111,575 | ​ | $ | 61,906 | ​ | $ | 173,481
Cardiac Intervention | ​ |  | 51,293 | ​ | ​ | 87,303 | ​ |  | 138,596 | ​ |  | 56,161 | ​ |  | 96,022 | ​ |  | 152,183
Custom Procedural Solutions | ​ |  | 48,797 | ​ | ​ | 44,143 | ​ |  | 92,940 | ​ |  | 48,965 | ​ |  | 44,112 | ​ |  | 93,077
OEM | ​ |  | 47,274 | ​ | ​ | 9,201 | ​ |  | 56,475 | ​ |  | 49,904 | ​ |  | 8,501 | ​ |  | 58,405
Total | ​ |  | 245,780 | ​ | ​ | 201,941 | ​ |  | 447,721 | ​ |  | 266,605 | ​ |  | 210,541 | ​ |  | 477,146
​ | ​ |  | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Endoscopy | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Endoscopy devices | ​ |  | 13,416 | ​ |  | 759 | ​ |  | 14,175 | ​ |  | 16,117 | ​ |  | 618 | ​ |  | 16,735
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Total | ​ | $ | 259,196 | ​ | $ | 202,700 | ​ | $ | 461,896 | ​ | $ | 282,722 | ​ | $ | 211,159 | ​ | $ | 493,881
​ ​

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -URI http://asc.fasb.org/topic&trid=49130388 + Details
Name: | us-gaap_RevenueFromContractWithCustomerTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration